medac

Our Mission

To improve patient's quality of life by providing high-quality therapies1

All risk classes

medac offers a dual first-line treatment2 concept for the adjuvant treatment of non-muscle-invasive bladder cancer. Powered by the patients´ needs and to increase the personal safety of users, medac developed the first closed instillation system which is today equipped as standard with our compounds.

40 years experience

Instillation therapies in non-muscle-invasive bladder cancer (NMIBC) have a long tradition for our company. We have been successful in NMIBC therapy for over 40 years.

Providing reliability in an undersupplied market

By continually developing our expertise over many years, we have been able to reliably serve the undersupplied NMIBC market with preparations for all risk classes, making our products available to patients in need. Our mission is to improve the quality of life of patients in the long term through high-quality therapies. That is why we continually strive to make advances in the treatment of NMIBC.

Highly appreciated service and competence

We can proudly say that our services and competence are highly appreciated by healthcare professionals from all over the world. Together, we get to the bottom of things.

About medac

medac Group, since 1970, strives to improve human health by providing high quality medical treatments. Headquartered in Germany, we operate in 91 countries, employing over 2,000 people. Our pharmaceuticals, produced to the highest standards in Germany and Europe, are distributed worldwide. Specialized in rheumatology, urology, hematology, and oncology, we focus on improving authorized medicines and developing innovative therapies. Committed to safety and quality, we offer original products, generics, and biosimilars, ensuring vital treatments are available worldwide.

References

1.    Grabe-Heyne K, et al. J Med Econ. 2023; 26(1):411-21 - 2.    according to guidelines on treatment of NMIBC by EAU / AUA / BAUS and many more

NMIBC

Discover the associated guidelines, which NMIBC calculator can support you in your therapy decision and which treatment options medac offers in NMIBC treatment.
 

DIVE DEEPER